Basic Information
| RNALocate ID: | RLID-D:11001470 |
| RNA Symbol: | hsa-miR-29b-1-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-29b-1-5p |
| RNA ID: | miRBase:MIMAT0004514 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002584 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003621 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000591 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-29b-1-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-35054 |
| MNDR | hsa-miR-29b-1-5p | Medulloblastoma | MNDR-E-MI-35055 |
| MNDR | hsa-miR-29b-1-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-35056 |
| MNDR | hsa-miR-29b-1-5p | Lymphoma | MNDR-E-MI-35057 |
| MNDR | hsa-miR-29b-1-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-35058 |
| MNDR | hsa-miR-29b-1-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-35059 |
| MNDR | hsa-miR-29b-1-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-35060 |
| MNDR | hsa-miR-29b-1-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-35061 |
| MNDR | hsa-miR-29b-1-5p | Her2-receptor positive breast cancer | MNDR-E-MI-35062 |
| MNDR | hsa-miR-29b-1-5p | Prostate cancer | MNDR-E-MI-35063 |
| MNDR | hsa-miR-29b-1-5p | Gastric cancer | MNDR-E-MI-35064 |
| MNDR | hsa-miR-29b-1-5p | Alzheimer disease | MNDR-E-MI-35065 |
| MNDR | hsa-miR-29b-1-5p | Seizures | MNDR-E-MI-35066 |
| MNDR | hsa-miR-29b-1-5p | Lung cancer | MNDR-E-MI-35067 |
| MNDR | hsa-miR-29b-1-5p | Parkinson disease | MNDR-E-MI-35068 |
| MNDR | hsa-miR-29b-1-5p | Breast cancer | MNDR-E-MI-35069 |
| MNDR | hsa-miR-29b-1-5p | Pituitary neoplasms | MNDR-E-MI-35070 |
| MNDR | hsa-miR-29b-1-5p | Pancreatic cancer | MNDR-E-MI-35071 |
| MNDR | hsa-miR-29b-1-5p | Colon cancer | MNDR-E-MI-35072 |
| MNDR | hsa-miR-29b-1-5p | Colon adenocarcinoma | MNDR-E-MI-35073 |
| MNDR | hsa-miR-29b-1-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-35074 |
| MNDR | hsa-miR-29b-1-5p | Familial ovarian cancer | MNDR-E-MI-35075 |
| MNDR | hsa-miR-29b-1-5p | Acromegaly | MNDR-E-MI-35076 |
| MNDR | hsa-miR-29b-1-5p | Prostate adenocarcinoma | MNDR-E-MI-35077 |
| MNDR | hsa-miR-29b-1-5p | Carcinoma ductal breast | MNDR-E-MI-35078 |
| MNDR | hsa-miR-29b-1-5p | Glioma | MNDR-E-MI-35079 |
| MNDR | hsa-miR-29b-1-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-35080 |
| MNDR | hsa-miR-29b-1-5p | Osteosarcoma | MNDR-E-MI-35081 |
| MNDR | hsa-miR-29b-1-5p | Mesenchymal cancer | MNDR-E-MI-35082 |
| MNDR | hsa-miR-29b-1-5p | Gastric adenocarcinoma | MNDR-E-MI-35083 |
| MNDR | hsa-miR-29b-1-5p | Pituitary adenoma | MNDR-E-MI-35084 |
| MNDR | hsa-miR-29b-1-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-35085 |
| MNDR | hsa-miR-29b-1-5p | Lung adenocarcinoma | MNDR-E-MI-35086 |
| MNDR | hsa-miR-29b-1-5p | Thyroid carcinoma | MNDR-E-MI-35087 |
| MNDR | hsa-miR-29b-1-5p | Pancreatic adenocarcinoma | MNDR-E-MI-35088 |
| MNDR | hsa-miR-29b-1-5p | Carcinoma renal cell | MNDR-E-MI-35089 |
| MNDR | hsa-miR-29b-1-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-35090 |
| MNDR | hsa-miR-29b-1-5p | Renal clear cell carcinoma | MNDR-E-MI-35091 |
| MNDR | hsa-miR-29b-1-5p | Lung small cell carcinoma | MNDR-E-MI-35092 |
| MNDR | hsa-miR-29b-1-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-35093 |
| MNDR | hsa-miR-29b-1-5p | Testicular germ cell cancer | MNDR-E-MI-35094 |
| MNDR | hsa-miR-29b-1-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-35095 |
| MNDR | hsa-miR-29b-1-5p | Breast invasive carcinoma | MNDR-E-MI-35096 |
| MNDR | hsa-miR-29b-1-5p | Hepatocellular carcinoma | MNDR-E-MI-35097 |
| MNDR | hsa-miR-29b-1-5p | Embryonal cancer | MNDR-E-MI-35098 |
| MNDR | hsa-miR-29b-1-5p | Familiar ovarian carcinoma | MNDR-E-MI-35099 |
| MNDR | hsa-miR-29b-1-5p | B-cell lymphoma | MNDR-E-MI-35100 |
| MNDR | hsa-miR-29b-1-5p | Malignant pleural mesothelioma | MNDR-E-MI-35101 |
| MNDR | hsa-miR-29b-1-5p | Hodgkin lymphoma | MNDR-E-MI-35102 |
| MNDR | hsa-miR-29b-1-5p | Skin cutaneous melanoma | MNDR-E-MI-35103 |
| MNDR | hsa-miR-29b-1-5p | Skin melanoma | MNDR-E-MI-35104 |
| MNDR | hsa-miR-29b-1-5p | Colorectal cancer | MNDR-E-MI-35105 |
| MNDR | hsa-miR-29b-1-5p | Multiple myeloma | MNDR-E-MI-35106 |
| MNDR | hsa-miR-29b-1-5p | Wounds and injuries | MNDR-E-MI-35107 |
| MNDR | hsa-miR-29b-1-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-35108 |
| MNDR | hsa-miR-29b-1-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-35109 |
| MNDR | hsa-miR-29b-1-5p | Stroke lacunar | MNDR-E-MI-35110 |
| MNDR | hsa-miR-29b-1-5p | Breast cancer her3+ negative | MNDR-E-MI-35111 |
| MNDR | hsa-miR-29b-1-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-35112 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AKT3 | Homo sapiens | RR00067431 |
TOP